Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer

Annals of Oncology

Volumn 17, Issue 3, 2006, Pages 401-408

  Ford, H T ^a   Coombes, R C ^b   Gazet, J C ^a,d   Gray, R ^c   McConkey, C C ^c   Sutcliffe, R ^a   Quilliam, J ^a   Lowndes, S ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c Clinical Trials Unit   (United Kingdom)

^d NONE   (United Kingdom)

Author keywords

Breast cancer trial; Chemoendocrine therapy; Conservative surgery; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; METASTASIS; PATIENT MONITORING; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK ASSESSMENT; RISK REDUCTION; TIME; TIME OF DEATH;

EID: 33644684185     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdj080     Document Type: Article

References (36)

1. Hughes LE, Forbes TF. Review article: Early breast cancer: Part II. Management. Br J Surg 1978; 65: 764-772.
2. Working Party of the Cancer Research Campaign Trial. Management of early cancer of the breast. BMJ 1976; 1: 1035-1038.
3. Fisher B, Slack N, Cavanaugh PJ et al. Post-operative radiotherapy in the treatment of breast cancer: Results of NSABP clinical trial. Ann Surg 1970; 172: 711-732.
4. Eason EC. Post-operative Radiotherapy in Breast Cancer: Symposium on Prognostic Factors in Breast Cancer. Edinburgh: Livingstone 1968.
5. Fisher B, Glass A, Redmon C et al. L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L-PAM plus 5 Fluorouracil (5 FU). Cancer 1977; 39: 2883-2903.
6. Bonadonna G, Rossi A, Valagussa P et al. The CMF programme for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval site of relapse and drug tolerance. Cancer 1977; 39: 2904-2915.
7. Clark RM, Whelan T, Levine M et al. Randomised clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. An update. J Natl Cancer Inst 1996; 88: 1659-1664.
8. Liljegren G, Holmberg L, Bergh J et al. 10-Year results after sector resection with or without postoperative radiotherapy for Stage I breast cancer: A randomised trial. J Clin Oncol 1999; 17: 2326-2333.
9. Holli K, Saristo R. Isola J et al. Lumpectomy with or without postoperative radiotherapy for small breast cancer with favourable prognostic features: Results of a randomised study. Br J Cancer 2001; 84: 164-169.
10. Veronesi U, Marubini E, Mariani L et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001; 12: 997-1003.
11. Fisher B, Stewart MD, Anderson H et al. Twenty year follow up of a randomised trial comparing total mastectomy, lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 1233-1241.
12. Malmstrom P, Holmberg L, Anderson H et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: A randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 2003; 39: 1690-1697.
13. Forrest P, Stewart H, Everington D et al. Randomised controlled trial of conservation therapy for breast carcinoma: 6-year analysis of the Scottish trial. Lancet 1990; 348: 708-713.
14. Liljegren G. Is post-operative radiotherapy after breast conserving surgery always mandatory? A review of randomised controlled trials. Scand J Surg 2002; 91: 251-254.
15. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 2000; 355: 1757-1770.
16. Coombes RC, Powles T, Gazet J-C. Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet 1980; 1: 296-298.
17. McClelland RA, Berger U, Miller IS et al. Immunocytochemical assay for estrogen receptor in patients with breast cancer; relationship to a biochemical assay and to outcome of therapy; J Clin Oncol 1986; 4: 1171-1176.
18. Coombes RC, Powles TJ, Berger U et al. Prediction of endocrine response in breast cancer by immunocyto-chemical detection of oestrogen receptor in fine needle aspirates. Lancet 1987; ii: 701-703.
19. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
20. Peto R, Pike MC, Armitage P et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient II. Analysis and example. Br J Cancer 1977; 35: 1-39.
21. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer. An overview of the randomised trials. N Engl J Med 1995; 333: 1444-1455.
22. Renton SC, Gazet J-C, Ford HT et al. The importance of the resection margins in conservative surgery for breast cancer. Eur J Surg Oncol 1996; 22: 17-22.
23. Meric F, Mirza NQ, Vlastos G et al. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast conserving therapy. Cancer 2003; 97: 926-933.
24. Marty ME, Coombes RC, Peckitt C et al. Prospective analysis of randomised trials of CMF vs. FEC chemotherapy in early breast cancer. Proc Am Soc Clin Oncol 2004; 23: 25 (Abstr 592).
25. Whelan T, Clark R, Roberts R et al. Ipsilateral breast tumour recurrence post-lumpectomy is predictive of subsequent mortality: Results from a randomised trial. Int J Radiat Oncol Biol Phys 1994; 30: 11-16.
26. Veronesi U, Volterrani F, Luini A et al. Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 1991; 26: 671-673.
27. Fisher B, Redmon C, Poisson R et al. Eight year results of a randomised clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989; 320: 822-828.
28. Hayward JL, Winter PJ, Tong D et al. A new combined approach to the conservative treatment of early breast cancer. Surgery 1984; 95: 270-274.
29. Haybittle JL, Brinkler D, Houghton J et al. Post-operative radiotherapy and late mortality evidence from the Cancer Research Campaign Trial for early breast cancer. BMJ 1989; 298: 1611-1614.
30. Palmer MK, Ribeiro GG. Thirty-four year follow up of patients with breast cancer in clinical trial of post-operative radiotherapy. BMJ 1985; 291: 1088-1091.
31. Fuller GA, Haybittle JL, Smith REA et al. Cardiac doses in postoperative breast irradiation. Radiother Oncol 1992; 25: 19-24.
32. Recht A, Come GE, Harris JR. Integration of conservative surgery, radiotherapy and chemotherapy for patients with early stage breast cancer. Semin Radiat Oncol 1992; 2: 107-115.
33. Vicini F, Kestin L, Huang R et al. Does local recurrence affect the rate of distant metastases and survival in patients with early stage breast carcinoma treated with breast-conserving therapy? Cancer 2003; 97: 926-932.
34. Mansi JL, Gogas H, Bliss JM et al. Outcome of primary breast cancer patients with micrometastases: A long term follow-up. Lancet 1999; 354: 197-202.
35. Mansi JL, Eason D, Berger U et al. Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years follow-up. Eur J Cancer 1991; 97: 1552-1555.
36. Athow AC, Gattuso JM, Perry N et al. Is radiotherapy needed after breast conservation for small invasive breast cancers? Eur J Surg Oncol 2002: 28: 379-382.